MDxHealth
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
29 mei 2008 - 08:23
Statutaire naam
MDxHealth
Titel
OncoMethylome’s Novel Test for Bladder Cancer Demonstrates Excellent Performance in Clinical Trial
Bericht
Liege (Belgium) – May 29, 2008, 08:00 CET – OncoMethylome Sciences (Euronext Brussels: ONCOB, Euronext Amsterdam: ONCOA) released additional data today from an ongoing clinical verification trial of their bladder cancer test.
- The new data confirms the ability of this non-invasive urine-based test to accurately detect early-stage bladder cancer
- The test procedure was successfully simplified without compromising performance
- Multi-center trial shows that the test is highly reproducible
Gerelateerde downloads
Datum laatste update: 28 juli 2024